Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 383046, 7 pages
http://dx.doi.org/10.1155/2015/383046
Research Article

Clinical Significance of SASH1 Expression in Glioma

1Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong 226001, China
2Key Laboratory of Neuroregeneration, Nantong University, Nantong 226001, China

Received 10 May 2015; Revised 20 August 2015; Accepted 23 August 2015

Academic Editor: Stamatios Theocharis

Copyright © 2015 Liu Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Sciumè, A. Santoni, and G. Bernardini, “Chemokines and glioma: invasion and more,” Journal of Neuroimmunology, vol. 224, no. 1-2, pp. 8–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. E. T. Sayegh, G. Kaur, O. Bloch, and A. T. Parsa, “Systematic review of protein biomarkers of invasive behavior in glioblastoma,” Molecular Neurobiology, vol. 49, no. 3, pp. 1212–1244, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Chan, X. Liu, L. Wang, L. Bardwell, Q. Nie, and G. Enciso, “Protein scaffolds can enhance the bistability of multisite phosphorylation systems,” PLoS Computational Biology, vol. 8, no. 6, Article ID e1002551, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Chodniewicz and R. L. Klemke, “Regulation of integrin-mediated cellular responses through assembly of a CAS/Crk scaffold,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1692, no. 2-3, pp. 63–76, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Zeller, B. Hinzmann, S. Seitz et al., “SASH1: a candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer,” Oncogene, vol. 22, no. 19, pp. 2972–2983, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Rimkus, M. Martini, J. Friederichs et al., “Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer,” British Journal of Cancer, vol. 95, no. 10, pp. 1419–1423, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Lin, J. Zhang, J. Xu et al., “Effects of SASH1 on melanoma cell proliferation and apoptosis in vitro,” Molecular Medicine Reports, vol. 6, no. 6, pp. 1243–1248, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. Meng, M. Zheng, H. Liu et al., “SASH1 regulates proliferation, apoptosis, and invasion of osteosarcoma cell,” Molecular and Cellular Biochemistry, vol. 373, no. 1-2, pp. 201–210, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. E.-G. Chen, Y. Chen, L.-L. Dong, and J.-S. Zhang, “Effects of SASH1 on lung cancer cell proliferation, apoptosis, and invasion in vitro,” Tumor Biology, vol. 33, no. 5, pp. 1393–1401, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. G. A. Alexiou and S. Voulgaris, “The role of the PTEN gene in malignant gliomas,” Neurologia i Neurochirurgia Polska, vol. 44, no. 1, pp. 80–86, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Marcel, M.-L. Dichtel-Danjoy, C. Sagne et al., “Biological functions of p53 isoforms through evolution: lessons from animal and cellular models,” Cell Death and Differentiation, vol. 18, no. 12, pp. 1815–1824, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Zhou, Z. Wei, S. Deng et al., “SASH1 regulates melanocyte transepithelial migration through a novel Galphas-SASH1-IQGAP1-E-Cadherin dependent pathway,” Cellular Signalling, vol. 25, no. 6, pp. 1526–1538, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Yang, M. Liu, Z. Gu, J. Chen, Y. Yan, and J. Li, “Overexpression of SASH1 related to the decreased invasion ability of human glioma U251 cells,” Tumour Biology, vol. 33, no. 6, pp. 2255–2263, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Huang, H. Zhu, J. Feng, S. Ni, and J. Huang, “High CD133 expression in the nucleus and cytoplasm predicts poor prognosis in non-small cell lung cancer,” Disease Markers, vol. 2015, Article ID 986095, 8 pages, 2015. View at Publisher · View at Google Scholar
  15. J. Feng, L. Xu, S. Ni et al., “Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity,” Oncotarget, vol. 5, no. 20, pp. 9689–9702, 2014. View at Google Scholar
  16. J. Huang, X. Zhang, Q. Tang et al., “Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma,” Journal of Clinical Pathology, vol. 64, no. 4, pp. 343–348, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Liu, R. Wu, F. Yang et al., “Identification of FN1BP1 as a novel cell cycle regulator through modulating G1 checkpoint in human hepatocarcinoma Hep3B cells,” PLoS ONE, vol. 8, no. 2, Article ID e57574, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Naguib, J. C. Cooke, L. Happerfield et al., “Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors,” BMC Cancer, vol. 11, article 123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Rajan, R. Elliott, O. Clewes et al., “Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours,” Oncogene, vol. 30, no. 41, pp. 4243–4260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Pustišek and M. Šitum, “Uv-radiation, apoptosis and skin,” Collegium Antropologicum, vol. 35, supplement 2, pp. 339–341, 2011. View at Google Scholar · View at Scopus
  21. Y.-J. Kim, Y.-E. Cho, Y.-W. Kim, J.-Y. Kim, S. Lee, and J.-H. Park, “Suppression of putative tumour suppressor gene GLTSCR2 expression in human glioblastomas,” The Journal of Pathology, vol. 216, no. 2, pp. 218–224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Qu, H. Jiao, J. Zhao et al., “Molecular genetic and epigenetic analysis of NCX2/SLC8A2 at 19q13.3 in human gliomas,” Neuropathology and Applied Neurobiology, vol. 36, no. 3, pp. 198–210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. X. Zhu, S. Benn, Z. H. Li et al., “The SH3-SAM adaptor HACS1 is up-regulated in B cell activation signaling cascades,” The Journal of Experimental Medicine, vol. 200, no. 6, pp. 737–747, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Beer, T. Scheikl, B. Reis, N. Hüser, K. Pfeffer, and B. Holzmann, “Impaired immune responses and prolonged allograft survival in Sly1 mutant mice,” Molecular and Cellular Biology, vol. 25, no. 21, pp. 9646–9660, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. C. A. Kim and J. U. Bowie, “SAM domains: uniform structure, diversity of function,” Trends in Biochemical Sciences, vol. 28, no. 12, pp. 625–628, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Aviv, Z. Lin, S. Lau, L. M. Rendl, F. Sicheri, and C. A. Smibert, “The RNA-binding SAM domain of Smaug defines a new family of post-transcriptional regulators,” Nature Structural Biology, vol. 10, no. 8, pp. 614–621, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. B. J. Mayer, “SH3 domains: complexity in moderation,” Journal of Cell Science, vol. 114, part 7, pp. 1253–1263, 2001. View at Google Scholar · View at Scopus